<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>+G306P718</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABS75+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.197Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P720</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABS150+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.173Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P721</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ASR2+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.156Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P724</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ASR6+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.139Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P725</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ASR12+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.122Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P726</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ASR25+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.110Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P727</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WAN60+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.095Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P728</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WAN70+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.069Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P730</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WSN230+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.058Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P731</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSF220+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.044Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P732</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSF350+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.017Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P733</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSF420+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.990Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P734</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSF420R+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.968Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P735</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSF640+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.943Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P736</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSF820R+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.922Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P737</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD450+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.902Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P738</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD550+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.876Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P739</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD750+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P741</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD950+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.825Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P742</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD1050+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.805Z</lastUpdated>
  </row>
</eudamedExport>